Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors

Published:2013-08-01 Issue:8 Volume:18 Page:900-908
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Lenihan Daniel J.¹,Kowey Peter R.²

Affiliation:

1. Vanderbilt Heart and Vascular Institute, Nashville, Tennessee, USA;

2. Jefferson Medical College and the Lankenau Institute for Medical Research, Main Line Health Heart Center, Wynnewood, Pennsylvania, USA

Abstract

Learning Objectives Describe the cardiovascular adverse events associated with TKI therapy for cancer. Develop strategies to minimize or mitigate CV adverse events during TKI treatment.

Funder

AstraZeneca LP

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2012-0466

Reference58 articles.

1. Tyrosine kinase inhibitors: Can promising new therapy associated with cardiac toxicity strengthen the concept of teamwork?;Lenihan;J Clin Oncol,2008

2. Why do kinase inhibitors cause cardiotoxicity and what can be done about it?;Cheng;Prog Cardiovasc Dis,2010

3. Mechanisms of cardiomyopathy associated with tyrosine kinase inhibitor cancer therapeutics;Chen;Circulation,2008

4. Cardiac dysfunction induced by novel targeted anticancer therapy: An emerging issue;Chen;Curr Cardiol Rep,2009

5. Molecularly targeted oncology therapeutics and prolongation of the QT interval;Strevel;J Clin Oncol,2007

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment;Drug Design, Development and Therapy;2024-09

2. Effects of Rowing on Cardiac Function in Breast Cancer Survivors: Sliding Seat Rowing vs. Fixed Seat Rowing;Applied Sciences;2024-07-18

3. Pharmacotherapy and cardiovascular challenges: a case report of olverembatinib-induced myocardial infarction with non-obstructive coronary arteries;BMC Cardiovascular Disorders;2024-07-02

4. New-onset keratitis associated with epidermal growth factor receptor-based targeted therapies in Han Chinese patients with lung cancer: A multi-center cohort study;The Ocular Surface;2024-07

5. In vitro PK/PD modeling of tyrosine kinase inhibitors in non‐small cell lung cancer cell lines;Clinical and Translational Science;2024-03